Evidence map›Paper›PMID 34099371›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2021

Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830].

K L Jhaveri, X V Wang, V Makker, S-W Luoh, E P Mitchell, J A Zwiebel, E Sharon, R J Gray, S Li, L M McShane and 10 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

K L JhaveriDepartment of Medicine, Memorial Sloan-Kettering Center, New York, USA. Electronic address: jhaverik@mskcc.org.
X V WangBiostatistics, E-A Biostatistical Center, Boston, USA.
V MakkerGynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
S-W LuohKnight Cancer Institute, Oregon Health Science University, Portland, USA.
E P MitchellMedical Oncology, Thomas Jefferson University, Philadelphia, USA.
J A ZwiebelInvestigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.
E SharonMedical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA.
R J GrayDepartment of Biostatistics, Dana Farber Cancer Institutes, Boston, USA.
S LiDepartment of Biostatistics, Dana Farber Cancer Institutes, Boston, USA.
L M McShaneBiometric Research Branch, National Cancer Institute, Bethesda, USA.
L V RubinsteinBiometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Bethesda, USA.
D PattonCenter for Biomedical, Informatics & Information Technology, National Cancer Institute, Bethesda, USA.
P M WilliamsMolecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, USA.
S R HamiltonDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA.
B A ConleyCancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.
C L ArteagaDepartment of Internal Medicine, University of Texas Southwestern, Dallas, USA.
L N HarrisCancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.
P J O'DwyerUniversity of Pennsylvania, Philadelphia, USA.
A P ChenCTEP, National Cancer Institute, Bethesda, USA.
K T FlahertyCancer Center, Massachusetts General Hospital, Boston, USA.
National Cancer Institute · USDana-Farber Cancer Institute · USMemorial Sloan Kettering Cancer Center · USBiostatistical Consulting (United States) · USFrederick National Laboratory for Cancer Research · USMassachusetts General Hospital · USOregon Health & Science University · USPhiladelphia University · USThe University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34099371
PMCPMC8929237
OpenAlexW3172947477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.